AMCADOP CV-50 – Cefpodoxime Proxetil 50 mg + Clavulanic Acid 31.25 mg Dry Syrup

AMCADOP CV-50 is a paediatric antibiotic dry syrup containing Cefpodoxime Proxetil equivalent to Cefpodoxime 50 mg and Clavulanic Acid 31.25 mg per 5 ml of reconstituted suspension. It combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor to provide antibacterial activity against susceptible bacterial infections.

AMCADOP CV-50 is supplied as a convenient oral dry syrup for paediatric use and is available with an orange flavour. The product is reconstituted with sterile water before administration as directed by the healthcare professional.

AMCADOP CV-50 Composition

Each 5 ml of reconstituted suspension contains:

• Cefpodoxime Proxetil IP equivalent to Cefpodoxime – 50 mg
• Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid – 31.25 mg
• Excipients – q.s.
• Flavoured base – q.s.
• Colour: Sunset Yellow

Dosage Form: Dry Syrup / Oral Suspension
Strength: Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg per 5 ml
Pack Size: 11 g/30 ml
Flavour: Orange
Target Segment: Paediatric
Route: Oral

Therapeutic Use of AMCADOP CV-50

AMCADOP CV-50 belongs to the Antibacterial & Antibiotics therapeutic category.

It may be prescribed for susceptible bacterial infections, including:

• Respiratory tract infections
• Acute bacterial bronchitis
• Community-acquired pneumonia
• Ear infections such as acute otitis media
• Skin and soft tissue infections
• Urinary tract infections
• Other susceptible bacterial infections as determined by a healthcare professional

AMCADOP CV-50 should be used only when bacterial infection is suspected or confirmed and antibiotic treatment is considered appropriate by a qualified healthcare professional.

Benefits of AMCADOP CV-50

• Contains Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg per 5 ml
• Convenient paediatric dry syrup formulation
• Orange flavour for improved palatability
• Combines an antibiotic with a beta-lactamase inhibitor
• Convenient oral dosage form for children
• Suitable for treatment of susceptible bacterial infections when prescribed by a doctor

How Does AMCADOP CV-50 Work?

AMCADOP CV-50 contains two active components: Cefpodoxime and Clavulanic Acid.

Cefpodoxime is a third-generation cephalosporin antibiotic that works by interfering with bacterial cell wall synthesis, thereby inhibiting the growth of susceptible bacteria.

Clavulanic Acid is a beta-lactamase inhibitor. Some bacteria produce enzymes called beta-lactamases that can reduce the effectiveness of certain antibiotics. Clavulanic Acid helps inhibit these enzymes and can extend the antibacterial activity of Cefpodoxime against susceptible beta-lactamase-producing bacteria.

AMCADOP CV-50 Dosage and Administration

The appropriate dose of AMCADOP CV-50 should be determined by the doctor based on the child’s age, body weight, type and severity of infection, kidney function and other clinical factors.

The dry syrup should be reconstituted with sterile water as directed on the product packaging or by the healthcare professional.

Shake the reconstituted suspension well before each dose and administer the prescribed quantity using an appropriate measuring device.

Do not increase the dose, reduce the dose or discontinue the treatment without consulting the doctor.

Possible Side Effects of AMCADOP CV-50

Some patients may experience mild side effects, including:

• Diarrhea
• Nausea
• Vomiting
• Abdominal discomfort
• Indigestion
• Headache
• Skin rash

If the child develops difficulty breathing, swelling of the face or throat, severe skin reactions, persistent or severe diarrhea, or other serious symptoms, seek immediate medical attention.

Precautions for AMCADOP CV-50

Before using AMCADOP CV-50, inform the doctor if the child:

• Has an allergy to Cefpodoxime or other cephalosporin antibiotics
• Has had an allergic reaction to penicillins or other beta-lactam antibiotics
• Has kidney problems
• Has experienced antibiotic-associated diarrhea previously
• Is taking other medicines
• Has any significant underlying medical condition

AMCADOP CV-50 should be administered under appropriate medical supervision.

AMCADOP CV-50 and Antibiotic Resistance

Antibiotics should be used responsibly. AMCADOP CV-50 should not be used for viral infections such as common cold or influenza.

The prescribed course should be followed according to the doctor’s instructions. Unnecessary or inappropriate antibiotic use may contribute to antibiotic resistance.

Frequently Asked Questions About AMCADOP CV-50

What is AMCADOP CV-50?

AMCADOP CV-50 is a paediatric dry syrup containing Cefpodoxime equivalent to 50 mg and Clavulanic Acid 31.25 mg per 5 ml after reconstitution.

What is AMCADOP CV-50 used for?

AMCADOP CV-50 may be prescribed for susceptible bacterial infections such as respiratory tract infections, ear infections, skin and soft tissue infections and urinary tract infections.

What is the composition of AMCADOP CV-50?

Each 5 ml of reconstituted suspension contains Cefpodoxime equivalent to 50 mg and Clavulanic Acid equivalent to 31.25 mg.

Is AMCADOP CV-50 suitable for children?

AMCADOP CV-50 is a dry syrup formulation intended for paediatric use. The dose should be determined by a qualified healthcare professional according to the child’s condition and body weight.

What flavour is AMCADOP CV-50?

AMCADOP CV-50 has an orange flavour, as shown on the product packaging.

What is the pack size of AMCADOP CV-50?

The product shown is supplied as 11 g/30 ml Dry Syrup.

Can AMCADOP CV-50 be used for cold and flu?

No. AMCADOP CV-50 is an antibiotic and does not treat viral infections such as common cold or influenza. It should be used only when prescribed for an appropriate bacterial infection.

How should AMCADOP CV-50 Dry Syrup be prepared?

The dry syrup should be reconstituted using sterile water according to the instructions on the product pack or as directed by the healthcare professional.